Babies born to HIV-positive mothers and given the antiretroviral drug nevirapine through the first six weeks of life to prevent infection via breast-feeding are at high risk for developing drug-resistant HIV if they get infected anyway, a team of researchers report. But the investigators highlight the proven superiority of the six-week regimen in preventing mother-to-child HIV transmission in breast-fed infants.

For more information; http://www.hopkinschildrens.org/Prolonged-Nevirapine-in-Breast-Fed-Babies-Prevents-HIV-Infection-But-Leads-To-Drug-Resistant-HIV.aspx